Toggle light / dark theme

Radical Remission l Meet the Creator Kelly Turner

Meet the Creator and Director of the Radical Remission Docuseries! 👋
For the past fifteen years, Kelly Turner, Ph.D. has conducted research in 10 countries and analyzed over 1500 cases of radical remission. She slowly began interviewing these radical remission survivors—one by one—until their stories filled the pages of her notebook
enough to fill a book, in fact.
Her book Radical Remission went on to be a New York Times bestseller, and now, it’s a docuseries, too—brought to you by Hay House Productions and directed by Kelly Turner herself.
The inspiring Radical Remission Docuseries starts on March 16th — but you can register here now!

👉 https://hhafftrk.com?a=8372&c=8169&p=r&utm_campaign=aff_8372_social_opt-in

‘Miracle poison’ for novel therapeutics

But the “miracle poison,” as it’s also known, has been approved by the F.D.A. to treat a suite of maladies like chronic migraines, uncontrolled blinking, and certain muscle spasms. And now, a team of researchers from Harvard University and the Broad Institute have, for the first time, proved they could rapidly evolve the toxin in the laboratory to target a variety of different proteins, creating a suite of bespoke, super-selective proteins called proteases with the potential to aid in neuroregeneration, regulate growth hormones, calm rampant inflammation, or dampen the life-threatening immune response called cytokine storm.


When people hear botulinum toxin, they often think one of two things: a cosmetic that makes frown lines disappear or a deadly poison.

/* */